↓ Skip to main content

Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease – a combined tissue microarray, in vitro and in vivo study

Overview of attention for article published in BMC Cancer, May 2013
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
49 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease – a combined tissue microarray, in vitro and in vivo study
Published in
BMC Cancer, May 2013
DOI 10.1186/1471-2407-13-250
Pubmed ID
Authors

Ágnes Márk, Melinda Hajdu, Zsófia Váradi, Tamás Béla Sticz, Noémi Nagy, Judit Csomor, Lajos Berczi, Viktória Varga, Monika Csóka, László Kopper, Anna Sebestyén

Abstract

Targeting signaling pathways is an attractive approach in many malignancies. The PI3K/Akt/mTOR pathway is activated in a number of human neoplasms, accompanied by lower overall and/or disease free survival. mTOR kinase inhibitors have been introduced in the therapy of renal cell carcinoma and mantle cell lymphoma, and several trials are currently underway. However, the pathological characterization of mTOR activity in lymphomas is still incomplete.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 2%
Unknown 48 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 18%
Researcher 9 18%
Student > Master 5 10%
Student > Doctoral Student 4 8%
Student > Bachelor 4 8%
Other 8 16%
Unknown 10 20%
Readers by discipline Count As %
Medicine and Dentistry 19 39%
Agricultural and Biological Sciences 9 18%
Immunology and Microbiology 3 6%
Biochemistry, Genetics and Molecular Biology 3 6%
Unspecified 1 2%
Other 2 4%
Unknown 12 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 May 2013.
All research outputs
#7,428,992
of 22,711,242 outputs
Outputs from BMC Cancer
#2,056
of 8,259 outputs
Outputs of similar age
#65,644
of 195,606 outputs
Outputs of similar age from BMC Cancer
#36
of 96 outputs
Altmetric has tracked 22,711,242 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,259 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 195,606 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 96 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.